当前位置: X-MOL 学术J. Hepatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Transitions in the nomenclatures for fatty liver disease
Journal of Hepatology ( IF 26.8 ) Pub Date : 2024-12-17 , DOI: 10.1016/j.jhep.2024.12.019
Maito Suoh, Saeed Esmaili, Mohammed Eslam, Jacob George

Section snippets

Clinical trial number:

Not applicable.

Authors’ contributions

The conception, data collection, and drafting the manuscript were performed by MS and ME. All authors critically reviewed, revised, and approved the final manuscript.

Data availability statement

The R code for the analysis was deposited in GitHub (https://github.com/maitosuoh/fatty-liver-time-series).

Financial support

SE, ME, and JG are supported by the Robert W. Storr Bequest to the Sydney Medical Foundation, The University of Sydney; a National Health and Medical Research Council of Australia (NHMRC) Program Grant (APP1053206), Project, Ideas and Investigator Grants (APP2001692, GNT1107178, GNT1108422, GNT1196492, GNT2008983) and a Cancer Institute, NSW grant (2021/ATRG2028).

Declaration of Competing Interest

The authors declare that they have no conflict of interest. Please refer to the accompanying ICMJE disclosure forms for further details.

Acknowledgements

Not applicable.


中文翻译:


脂肪肝疾病命名法的转变


 部分片段

 临床试验编号:

 不適用。

 作者的贡献


构思、数据收集和手稿起草由 MS 和 ME 进行。所有作者都严格审查、修改和批准了最终手稿。


数据可用性声明


用于分析的 R 代码存放在 GitHub (https://github.com/maitosuoh/fatty-liver-time-series) 中。

 财务支持


SE、ME 和 JG 得到了悉尼大学悉尼医学基金会 Robert W. Storr 遗赠的支持;澳大利亚国家健康与医学研究委员会 (NHMRC) 计划拨款 (APP1053206)、项目、想法和研究者拨款(APP2001692、GNT1107178、GNT1108422、GNT1196492、GNT2008983)和新南威尔士州癌症研究所拨款 (2021/ATRG2028)。


利益争夺声明


作者声明他们没有利益冲突。有关更多详细信息,请参阅随附的 ICMJE 披露表。

 确认

 不適用。
更新日期:2024-12-18
down
wechat
bug